HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 54 filers reported holding HARPOON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 156 | -97.3% | 0.00% | – |
| Q1 2022 | $29,000 | -34.1% | 5,775 | 0.0% | 0.00% | – |
| Q4 2021 | $44,000 | -4.3% | 5,775 | -0.6% | 0.00% | – |
| Q3 2021 | $46,000 | -80.8% | 5,809 | -66.5% | 0.00% | – |
| Q2 2021 | $240,000 | +9.1% | 17,331 | +64.8% | 0.00% | – |
| Q1 2021 | $220,000 | +25.7% | 10,519 | 0.0% | 0.00% | – |
| Q4 2020 | $175,000 | -2.2% | 10,519 | 0.0% | 0.00% | – |
| Q3 2020 | $179,000 | +2.3% | 10,519 | 0.0% | 0.00% | – |
| Q2 2020 | $175,000 | +207.0% | 10,519 | +113.8% | 0.00% | – |
| Q1 2020 | $57,000 | -21.9% | 4,919 | 0.0% | 0.00% | – |
| Q4 2019 | $73,000 | +9.0% | 4,919 | 0.0% | 0.00% | – |
| Q3 2019 | $67,000 | +857.1% | 4,919 | +883.8% | 0.00% | – |
| Q2 2019 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $24,938,000 | 7.19% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $24,738,000 | 5.73% |
| MPM BioImpact LLC | 3,196,707 | $25,254,000 | 3.92% |
| Affinity Asset Advisors, LLC | 250,000 | $1,975,000 | 0.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 215,000 | $1,696,000 | 0.41% |
| Orbimed Advisors | 2,611,308 | $20,629,000 | 0.23% |
| DAFNA Capital Management LLC | 105,163 | $831,000 | 0.22% |
| Avidity Partners Management LP | 1,190,600 | $9,406,000 | 0.21% |
| Artal Group S.A. | 1,000,000 | $7,900,000 | 0.18% |
| Cormorant Asset Management, LP | 540,600 | $4,271,000 | 0.17% |